TIM
DWTX

Tevis Investment Management’s Dogwood Therapeutics DWTX Stock Holding History

Tevis Investment Management’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3
Closed – – 487
2022
Q2 		$0 Buy
+3
New +$314 ﹤0.01% 525
2022
Q1 		– Sell
-3
Closed -$1K – 518
2021
Q4 		$1K Buy
+3
New +$382 ﹤0.01% 542

Other funds holding DWTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tevis Investment Management's DWTX Position: Q3 2022 in Review

Tevis Investment Management sold out of Dogwood Therapeutics (DWTX) in Q3 2022, closing a stake of 3 shares.

Tevis Investment Management first reported a position in DWTX in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q4 2021. 25 funds tracked by Wall St. Rank hold DWTX as of Q3 2022.

  • Tevis Investment Management reported no remaining Dogwood Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Tevis Investment Management sold 3 Dogwood Therapeutics shares in Q3 2022.
  • Tevis Investment Management first reported a position in Dogwood Therapeutics in Q4 2021 and held it in 2 quarters.
  • Tevis Investment Management's Dogwood Therapeutics position peaked at $1K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2022.

Based on Tevis Investment Management's 13F filing for Q3 2022, filed 7 Nov 2022.